| 纯度 | >95%SDS-PAGE. |
| 种属 | Human |
| 靶点 | PSMA1 |
| Uniprot No | P25786 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-263aa |
| 氨基酸序列 | MGSSHHHHHH SSGLVPRGSH MGSMFRNQYD NDVTVWSPQG RIHQIEYAME AVKQGSATVG LKSKTHAVLV ALKRAQSELA AHQKKILHVD NHIGISIAGL TADARLLCNF MRQECLDSRF VFDRPLPVSR LVSLIGSKTQ IPTQRYGRRP YGVGLLIAGY DDMGPHIFQT CPSANYFDCR AMSIGARSQS ARTYLERHMS EFMECNLNEL VKHGLRALRE TLPAEQDLTT KNVSIGIVGK DLEFTIYDDD DVSPFLEGLE ERPQRKAQPA QPADEPAEKA DEPMEH |
| 预测分子量 | 32 kDa i |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于PSMA1重组蛋白的3篇参考文献及其摘要概括：
1. **文献名称**：*"Recombinant expression and structural analysis of the proteasome subunit α1 (PSMA1) from human"*
**作者**：Mitsui et al.
**摘要**：研究通过大肠杆菌系统成功表达并纯化了重组人PSMA1蛋白，利用冷冻电镜技术解析其三维结构，揭示了其在20S蛋白酶体组装中的关键构象变化，为蛋白酶体功能机制提供了结构基础。
2. **文献名称**：*"Functional reconstitution of human proteasome subunits using recombinant PSMA1 for drug screening"*
**作者**：Zhang R, et al.
**摘要**：通过重组PSMA1与其他亚基共表达，体外重构功能性20S蛋白酶体，并用于筛选靶向蛋白酶体的抑制剂，证实重组PSMA1在药物开发中的实用性。
3. **文献名称**：*"High-yield production of recombinant PSMA1 in insect cells and its role in neurodegenerative disease models"*
**作者**：Kumar S, et al.
**摘要**：采用昆虫细胞表达系统高效制备重组PSMA1.发现其在阿尔茨海默病模型中异常聚集的蛋白降解中活性降低，提示其病理机制中的潜在作用。
4. **文献名称**：*"Biochemical characterization of PSMA1 mutations affecting proteasome activity"*
**作者**：García-Castro A, et al.
**摘要**：通过重组PSMA1突变体的表达，分析其与蛋白酶体活性的关系，发现特定突变导致底物水解效率下降，为癌症耐药性研究提供新视角。
(注：上述文献信息为示例性质，实际引用时需核对真实来源。)
**Background of PSMA1 Recombinant Protein**
PSMA1 (Proteasome 20S Subunit Alpha 1) is a critical component of the 20S core particle of the proteasome, a large protein complex responsible for the degradation of ubiquitinated proteins in eukaryotic cells. As part of the ubiquitin-proteasome system, PSMA1 plays a central role in maintaining cellular homeostasis by regulating protein turnover, which impacts processes like cell cycle progression, apoptosis, and stress response. Structurally, the 20S proteasome consists of four stacked rings: two outer α-rings (containing PSMA1 and other α-subunits) and two inner β-rings. PSMA1. located in the α-ring, facilitates substrate recognition and gating, ensuring controlled access to the proteolytic core.
Recombinant PSMA1 protein is engineered using expression systems like *E. coli* or mammalian cells, enabling high-purity production for research applications. Its recombinant form retains structural and functional integrity, making it valuable for studying proteasome assembly, substrate interactions, and inhibition mechanisms. Researchers utilize PSMA1 recombinant protein to investigate diseases linked to proteasome dysfunction, such as cancer, neurodegenerative disorders (e.g., Alzheimer’s and Parkinson’s), and autoimmune conditions. Additionally, it serves as a tool for drug discovery, particularly in developing proteasome inhibitors (e.g., bortezomib) for targeted therapies.
The production of recombinant PSMA1 often involves affinity tags (e.g., His-tag) for simplified purification, followed by validation via SDS-PAGE, Western blot, or activity assays. Its availability accelerates mechanistic studies and underscores its importance in understanding proteasomal regulation and therapeutic targeting.
×
